Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gluten and Amylase Trypsin Inhibitors (ATI) as Nutritional Contributors to Type 1 Diabetes Susceptibility

NCT03443180 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT03443180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03443180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gluten and Amylase Trypsin Inhibitors (ATI) as Nutritional Contributors to Type 1 Diabetes Susceptibility
Lead sponsor
Medical College of Wisconsin
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2018
Completion date
March 9, 2020
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type1diabetes